166 related articles for article (PubMed ID: 35037691)
1. Reconstitution of the DTX3L-PARP9 complex reveals determinants for high-affinity heterodimerization and multimeric assembly.
Ashok Y; Vela-Rodríguez C; Yang C; Alanen HI; Liu F; Paschal BM; Lehtiö L
Biochem J; 2022 Feb; 479(3):289-304. PubMed ID: 35037691
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitin Modification by the E3 Ligase/ADP-Ribosyltransferase Dtx3L/Parp9.
Yang CS; Jividen K; Spencer A; Dworak N; Ni L; Oostdyk LT; Chatterjee M; Kuśmider B; Reon B; Parlak M; Gorbunova V; Abbas T; Jeffery E; Sherman NE; Paschal BM
Mol Cell; 2017 May; 66(4):503-516.e5. PubMed ID: 28525742
[TBL] [Abstract][Full Text] [Related]
3. Synthetic Dual Cysteine-ADP Ribosylated Peptides from the Androgen Receptor are Recognized by the DTX3L/PARP9 Complex.
Wijngaarden S; Yang C; Vela-Rodríguez C; Lehtiö L; Overkleeft HS; Paschal BM; Filippov DV
ACS Chem Biol; 2023 Nov; 18(11):2377-2384. PubMed ID: 37939374
[TBL] [Abstract][Full Text] [Related]
4. Oligomerization mediated by the D2 domain of DTX3L is critical for DTX3L-PARP9 reading function of mono-ADP-ribosylated androgen receptor.
Vela-Rodríguez C; Yang C; Alanen HI; Eki R; Abbas TA; Maksimainen MM; Glumoff T; Duman R; Wagner A; Paschal BM; Lehtiö L
Protein Sci; 2024 Apr; 33(4):e4945. PubMed ID: 38511494
[TBL] [Abstract][Full Text] [Related]
5. The SARS-CoV-2 Nsp3 macrodomain reverses PARP9/DTX3L-dependent ADP-ribosylation induced by interferon signaling.
Russo LC; Tomasin R; Matos IA; Manucci AC; Sowa ST; Dale K; Caldecott KW; Lehtiö L; Schechtman D; Meotti FC; Bruni-Cardoso A; Hoch NC
J Biol Chem; 2021 Sep; 297(3):101041. PubMed ID: 34358560
[TBL] [Abstract][Full Text] [Related]
6. KH-like Domains in PARP9/DTX3L and PARP14 Coordinate Protein-Protein Interactions to Promote Cancer Cell Survival.
Saleh H; Liloglou T; Rigden DJ; Parsons JL; Grundy GJ
J Mol Biol; 2024 Feb; 436(4):168434. PubMed ID: 38182103
[TBL] [Abstract][Full Text] [Related]
7. Activities and binding partners of E3 ubiquitin ligase DTX3L and its roles in cancer.
Vela-Rodríguez C; Lehtiö L
Biochem Soc Trans; 2022 Dec; 50(6):1683-1692. PubMed ID: 36421918
[TBL] [Abstract][Full Text] [Related]
8. Oligomerisation mediated by the D2 domain of DTX3L is critical for DTX3L-PARP9 reading function of mono-ADP-ribosylated androgen receptor.
Vela-Rodríguez C; Yang C; Alanen HI; Eki R; Abbas TA; Maksimainen MM; Glumoff T; Duman R; Wagner A; Paschal BM; Lehtiö L
bioRxiv; 2023 Nov; ():. PubMed ID: 38076829
[TBL] [Abstract][Full Text] [Related]
9. Structural insights into ADP-ribosylation of ubiquitin by Deltex family E3 ubiquitin ligases.
Chatrin C; Gabrielsen M; Buetow L; Nakasone MA; Ahmed SF; Sumpton D; Sibbet GJ; Smith BO; Huang DT
Sci Adv; 2020 Sep; 6(38):. PubMed ID: 32948590
[TBL] [Abstract][Full Text] [Related]
10. Androgen signaling uses a writer and a reader of ADP-ribosylation to regulate protein complex assembly.
Yang CS; Jividen K; Kamata T; Dworak N; Oostdyk L; Remlein B; Pourfarjam Y; Kim IK; Du KP; Abbas T; Sherman NE; Wotton D; Paschal BM
Nat Commun; 2021 May; 12(1):2705. PubMed ID: 33976187
[TBL] [Abstract][Full Text] [Related]
11. DTX3L and ARTD9 inhibit IRF1 expression and mediate in cooperation with ARTD8 survival and proliferation of metastatic prostate cancer cells.
Bachmann SB; Frommel SC; Camicia R; Winkler HC; Santoro R; Hassa PO
Mol Cancer; 2014 May; 13():125. PubMed ID: 24886089
[TBL] [Abstract][Full Text] [Related]
12. DELTEX E3 ligases ubiquitylate ADP-ribosyl modification on nucleic acids.
Zhu K; Suskiewicz MJ; Chatrin C; Strømland Ø; Dorsey BW; Aucagne V; Ahel D; Ahel I
Nucleic Acids Res; 2024 Jan; 52(2):801-815. PubMed ID: 38000390
[TBL] [Abstract][Full Text] [Related]
13. A Study into the ADP-Ribosylome of IFN-γ-Stimulated THP-1 Human Macrophage-like Cells Identifies ARTD8/PARP14 and ARTD9/PARP9 ADP-Ribosylation.
Higashi H; Maejima T; Lee LH; Yamazaki Y; Hottiger MO; Singh SA; Aikawa M
J Proteome Res; 2019 Apr; 18(4):1607-1622. PubMed ID: 30848916
[TBL] [Abstract][Full Text] [Related]
14. PARP7 mono-ADP-ribosylates the agonist conformation of the androgen receptor in the nucleus.
Kamata T; Yang CS; Paschal BM
Biochem J; 2021 Aug; 478(15):2999-3014. PubMed ID: 34264286
[TBL] [Abstract][Full Text] [Related]
15. PARP9-DTX3L ubiquitin ligase targets host histone H2BJ and viral 3C protease to enhance interferon signaling and control viral infection.
Zhang Y; Mao D; Roswit WT; Jin X; Patel AC; Patel DA; Agapov E; Wang Z; Tidwell RM; Atkinson JJ; Huang G; McCarthy R; Yu J; Yun NE; Paessler S; Lawson TG; Omattage NS; Brett TJ; Holtzman MJ
Nat Immunol; 2015 Dec; 16(12):1215-27. PubMed ID: 26479788
[TBL] [Abstract][Full Text] [Related]
16. Studying Catabolism of Protein ADP-Ribosylation.
Palazzo L; James DI; Waddell ID; Ahel I
Methods Mol Biol; 2017; 1608():415-430. PubMed ID: 28695524
[TBL] [Abstract][Full Text] [Related]
17. Legionella metaeffector MavL reverses ubiquitin ADP-ribosylation via a conserved arginine-specific macrodomain.
Zhang Z; Fu J; Rack JGM; Li C; Voorneveld J; Filippov DV; Ahel I; Luo ZQ; Das C
Nat Commun; 2024 Mar; 15(1):2452. PubMed ID: 38503748
[TBL] [Abstract][Full Text] [Related]
18. ELTA: Enzymatic Labeling of Terminal ADP-Ribose.
Ando Y; Elkayam E; McPherson RL; Dasovich M; Cheng SJ; Voorneveld J; Filippov DV; Ong SE; Joshua-Tor L; Leung AKL
Mol Cell; 2019 Feb; 73(4):845-856.e5. PubMed ID: 30712989
[TBL] [Abstract][Full Text] [Related]
19. Iduna is a poly(ADP-ribose) (PAR)-dependent E3 ubiquitin ligase that regulates DNA damage.
Kang HC; Lee YI; Shin JH; Andrabi SA; Chi Z; Gagné JP; Lee Y; Ko HS; Lee BD; Poirier GG; Dawson VL; Dawson TM
Proc Natl Acad Sci U S A; 2011 Aug; 108(34):14103-8. PubMed ID: 21825151
[TBL] [Abstract][Full Text] [Related]
20. Identification of Poly(ADP-Ribose) Polymerase Macrodomain Inhibitors Using an AlphaScreen Protocol.
Ekblad T; Verheugd P; Lindgren AE; Nyman T; Elofsson M; Schüler H
SLAS Discov; 2018 Apr; 23(4):353-362. PubMed ID: 29316839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
